REQUEST A DEMO
Total
USD $0.00
Search more companies

Reszon Diagnostics International Sdn. Bhd. (Malaysia)

Main Activities: Glass and Glass Product Manufacturing
Full name: Reszon Diagnostics International Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Manufacturing of medical diagnostic products, medical testing laboratory, trading of laboratory equipment/scientific product and research and development of medical related product.

Headquarters
No. 12A, Jalan Tp5, Taman Perindustrian Uep
Subang Jaya; Selangor; Postal Code: 47600

Contact Details: Purchase the Reszon Diagnostics International Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Reszon Diagnostics International Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Reszon Diagnostics International Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Reszon Diagnostics International Sdn. Bhd. report to view the information.
Incorporation Date:
October 11, 2010
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Reszindo Biomed Sdn. Bhd.
50%
Company Performance
Financial values in the chart are available after Reszon Diagnostics International Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
16.47%
Total operating revenue
16.47%
Operating profit (EBIT)
62.26%
EBITDA
72.47%
Net Profit (Loss) for the Period
60.57%
Total assets
53.09%
Total equity
142.64%
Operating Profit Margin (ROS)
6.26%
Net Profit Margin
4.51%
Return on Equity (ROE)
-30.18%
Debt to Equity Ratio
-6.48%
Quick Ratio
3.18%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?